Portfolio comparison
University of Pennsylvania vs Gilead Sciences Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania
Patents indexed
2
Year range
2022
Most recent
2022
biotechpharmaceuticalgene_editing
Top Patents2 enriched
US 11499167· 2022
Engineering Cells to Make Gene Therapy Viruses Using AAVrh.10
US 11357868· 2022
New Adeno-Associated Virus Capsids for Gene Therapy
Activity by Decade
2020s2
Company B
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.